Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710380 · ClinicalTrials.gov registry record · NA
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
A NA study of Prostate Cancer and Prostate Adenocarcinoma, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05710380: Recruiting NA study of Prostate Cancer and Prostate Adenocarcinoma, sponsored by University of Chicago.
NCT05710380 is a NA study of Prostate Cancer and Prostate Adenocarcinoma that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 180 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05710380, a NA study of Prostate Cancer and Prostate Adenocarcinoma, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this research will last about 12 months. There is a one-time MRI and 1-2 biopsies and then the investigator would like to follow the participant's progress.
Primary Outcome
Compare the accuracy of the Risk Map Decision Support Systems (DSS) tool against the clinical accuracy of experienced radiologists in the context of the reference standard of biopsy histology.
Conditions Studied
Interventions
- OTHER Risk Map Decision Support System (DSS).
- RADIATION Magnetic Resonance Imaging (MRI)
- PROCEDURE Magnetic Resonance Imaging (MRI) Guided Biopsy
Study Locations (1)
Illinois
- University of Chicago Medicine Comprehensive Cancer Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
What NCT05710380 shows while recruiting
NCT05710380 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (70% lower).
The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Risk Map Decision Support System (DSS). is the first listed.
NCT05710380 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05710380 about?
NCT05710380 is a clinical study titled "MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy". Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this re...
What is the current status of trial NCT05710380?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-04-26. Estimated completion is 2026-05-01.
What conditions does trial NCT05710380 study?
This clinical trial studies the following conditions: Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm.
What interventions are being tested in trial NCT05710380?
The interventions under investigation include: Risk Map Decision Support System (DSS). (OTHER), Magnetic Resonance Imaging (MRI) (RADIATION), Magnetic Resonance Imaging (MRI) Guided Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05710380?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710380 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05710380's enrollment target sits among peer trials
180 240th of 735 higher than 493 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI